Clinical Trial Update: Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating probiotics combined with targeted therapy and immunotherapy in a bladder-preserving approach for muscle-invasive bladder …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Snippet

Sponsor: chenxu | Conditions: Muscle Invasive Bladder Cancer (MIBC) | Phase 2 | Status: NOT_YET_RECRUITING